Press Releases
| Washington, D.C. (Nov. 14, 2022)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent a letter to the National Archives and Records Administration (NARA) requesting presidential records to determine whether former President Trump distorted U.S. |
Washington, D.C. (Nov. 11, 2022)—Rep. Raja Krishnamoorthi, Chairman of the Subcommittee on Economic and Consumer Policy, and Rep.
| Washington, D.C. (Nov. 7, 2022)—Today, Rep. Carolyn B. |
Washington, D.C. (Nov. 3, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released new data showing the benefits of the Inflation Reduction Act for millions of Americans—across both Democratic and Republican congressional districts. This landmark law, which was passed by Democrats in Congress and signed into law by President Biden, will allow people across the country to get more affordable prescription drugs and lower health insurance premiums.
Washington D.C. (Oct. 27, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Sen.
| Washington, D.C. (Oct. 25, 2022)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, released a staff report entitled, Barriers to Birth Control: An Analysis of Contraceptive Coverage and Costs for Patients with Private Insurance. |
Washington, D.C. (Oct. 19, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, in partnership with Rep. Lauren Underwood and Rep. Alma S. Adams, Ph.D., Co-Chairs of the Black Maternal Health Caucus; Rep. Robin Kelly, Chair of the Congressional Black Caucus Health Braintrust; Oversight Committee Members Rep. Ayanna Pressley and Rep. Cori Bush; and Rep.
Washington, D.C. (October 18, 2022)—Today, Rep. Raja Krishnamoorthi, Chairman of the Subcommittee on Economic and Consumer Policy, issued the following statement in response to the Department of Justice (DOJ) filing complaints for permanent injunctions against six e-cigarette manufacturers on behalf of the Food and Drug Administration (FDA).